Navigation Links
A Vaccine for the impending pandemic Avian Influenza

All influenza viruses of the type A, including those causing seasonal epidemics of human influenza//, are genetically labile and well adapted to elude host defenses. The tendency of influenza viruses to undergo frequent and permanent antigenic changes necessitates constant monitoring of the global influenza situation and annual adjustments in the composition of influenza vaccines. Due to this tendency of mutation, avian influenza mixed with a human flu, and was thus able to infect humans through direct contact with birds.

According to the World Health Organization, of the 115 people in four Asian countries who have been infected with H5N1 from late 2003 through 2005, 59 have died. Vaccines are the principal medical intervention for protecting individuals against pandemic influenza. If available rapidly and in sufficient quantities, they can reduce the morbidity and mortality in pandemic situations.

According to a news posted on Sept 28, 2005, government scientists at the US National Institute of Allergy and Infectious Diseases (NIAID) announced results from initial clinical trials of a vaccine being developed to protect humans against infection with H5N1 avian influenza. NIAID and MedImmune have joined forces to develop potential pandemic influenza vaccines. HHS Secretary Mike Leavitt today announced that NIAID and MedImmune Inc. have signed a cooperative research and development agreement for the development of vaccines against avian influenza viruses that have the potential to cause pandemics. Speaking of pandemic flu as an urgent health challenge, HHS

Secretary Mike Leavitt said. “This agreement will help speed the process of developing vaccines we will need to fight an outbreak if the avian flu starts to spread rapidly through the human population.” As per the agreement, scientists will add selected genes from avian flu viruses with pandemic potential into a weakened human flu virus to create several attenuated, live virus v
'"/>




Page: 1 2

Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia

Post Your Comments:
(Date:12/3/2009)... 3 The following is bei..., U.S. Senate Judiciary Committee Chairman Patr...health care reform bill that would repeal the heal...tions such as price fixing, bid rigging and market...es the repeal, which would subject health insuranc...
(Date:12/3/2009)...n 1,500 Jobs Listed through APHA,s Public Health C...-USNewswire/ -- Today,s White House jobs summit re...ny professions, including public health. One publi...ect job seekers to more than 1,500 jobs in the hea...://www.apha.org/about/careers/ is a full online c...
(Date:12/3/2009)...ches rzteblatt International contains the first s...h the novel influenza A virus (H1N1/09) in the Ger...emic. Ralf Winzer and his coauthors from the Dssel... data from a large clinical cohort of infected per...: 770-6). Their medical-scientific article is acco...
(Date:12/3/2009)...atori World Medical, a leading global healthcare c... space, announced that international medical quali...Medical Quality Advisory Board (MQAB). , ...2009 –- Satori World Medical, a leading glob... medical travel space, announced that internationa...
(Date:12/3/2009)...wed, the more likely they were to light up, study ...ws) -- Seeing movie characters smoke cigarettes in...try smoking, according to a new study that calls f...ng. , It followed 1,328 Mexican-American adoles... types of movies they viewed. , At the start of...
Breaking Medicine News(10 mins):Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 2Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 3Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 4Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 5Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 6Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 7Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 8Health News:Public Health Jobs Site Available to Help Meet Growing Demand 2Health News:Former Chief Medical Officer of Joint Commission International Joins Satori World Medical's Medical Quality Advisory Board 2Health News:Former Chief Medical Officer of Joint Commission International Joins Satori World Medical's Medical Quality Advisory Board 3Health News:Former Chief Medical Officer of Joint Commission International Joins Satori World Medical's Medical Quality Advisory Board 4Health News:Movies May Tempt Teens to Smoke 2
...ts positive or negative emotional state has no dir...se progression, according to a large scale new stu...CER, a peer-reviewed journal of the American Cance...f whether or not the mind, through psychological s...
...t. 20 Nearly eight years of planning and,preparat...ted move from the,existing facility into the new s... one million square foot hospital brings together ...oncology and,obstetrics, the hospital offers care ...
...age of that extra hour of snooze-time, experts say... When the clocks go back an hour on the first Sund...make a small payment on your sleep debt, experts s...Stanford University Medical Center in Palo Alto, C...
... Oct. 19 Following is a statement,by Linda A. Suy...Products,Association (CHPA), regarding the recomme...ministration,s Nonprescription Drugs Advisory Comm...children., "For decades, parents and other caregi...
...ct. 19 A new survey released by the National,Alli...ic parents are,unaware of available resources for ...are of where to seek help for ADHD compared to,non...l Alliance for Hispanic Health,at: http://media.m...
... D. and Catherine T. MacArthur Foundation has prom...SF project to help combat maternal mortality in Ni...hird of all maternal deaths worldwide. , MacArth...ental organization Pathfinder International, which...
Other Medicine News:Health News:Cancer survival is not influenced by a patient's emotional status 2Health News:Northwestern Memorial Hospital Completes Move Into Its New Prentice Women's Hospital 2Health News:Northwestern Memorial Hospital Completes Move Into Its New Prentice Women's Hospital 3Health News:Fall Time Change Could Be Boon for Sleep 2Health News:Statement from the Consumer Healthcare Products Association on Today's Joint FDA Advisory Committee Recommendations Regarding Pediatric Over-the-Counter Cough and Cold Medicines 2Health News:MacArthur commits $11 million to further UCSF work in maternal safety 2Health News:MacArthur commits $11 million to further UCSF work in maternal safety 3
(Date:12/3/2009)..., NANJING, China, Dec. 3 /PRNewswire-Asia/ ..."Company") (NYSE: SCR ), a leading pharmaceutica...turing, and marketing of branded,generic and propr...at China,s,State Food and Drug Administration ("SF...nto quality issues regarding human use rabies vacc...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportlink... is available in its catalogue: ,, Immunoassay.../www.reportlinker.com/p0164367/Immunoassay-Instrum...ay and hematology markets have recorded significan...new technologies and introduction of new products....
(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportlinke...is available in its catalogue: ,, Electrodes f...,, http://www.reportlinker.com/p0164320/Electr...tive.html ,, Electrodes in electronic devices ...nerve cells that are created by chemical reactions...
Breaking Medicine Technology:Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen 2Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen 3Reportlinker Adds Immunoassay Instruments - Global Market Trends 2Reportlinker Adds Immunoassay Instruments - Global Market Trends 3Reportlinker Adds Immunoassay Instruments - Global Market Trends 4Reportlinker Adds Immunoassay Instruments - Global Market Trends 5Reportlinker Adds Immunoassay Instruments - Global Market Trends 6Reportlinker Adds Immunoassay Instruments - Global Market Trends 7Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 2Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 3Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 4Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 5Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 6Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 7Senator Bill Nelson Votes to Protect Americas Kids from Tobacco 48696 1Senator Bill Nelson Votes to Protect Americas Kids from Tobacco 48696 2Senators Specter and Casey Vote to Protect Americas Kids from Tobacco 48693 1Senators Specter and Casey Vote to Protect Americas Kids from Tobacco 48693 2Senators Feinstein and Boxer Vote to Protect Americas Kids from Tobacco 48690 1Senators Feinstein and Boxer Vote to Protect Americas Kids from Tobacco 48690 2
...rine Achieves Milestone as Third Phase II Trial in...ient Enrollment and Dosing -, TUSTIN, Calif., Aug...HM ) today announced that patient screening,and do...luate the safety,and efficacy of bavituximab in co...ced breast cancer. The new trial is the second Pha...
..., Va., Aug. 8 Innocoll, Inc., a privately-held,bi...atient has been dosed,in the first of three ongoin...owned subsidiary, Innocoll Technologies Ltd, to in...for the management of,post-operative pain., Innoc...ble and fully,bioresorbable matrix of purified fib...
Other Medicine Technology:Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer 2Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer 3Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer 4Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain 2Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain 3Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain 4
Multi Dop T1
EZ-Dop
...owerful automated system capable of handling any c...m 6 user-programmable test protocols to begin a fu...tests not included in the comprehensive list of au...ler, PVR and PPG instrument modes. Provides high f...
CD Horizon M10
Medicine Products: